Peter Altman - 16 Dec 2022 Form 4 Insider Report for BioCardia, Inc. (BCDA)

Role
President and CEO, Director
Signature
/s/ David McClung, by power of attorney
Issuer symbol
BCDA
Transactions as of
16 Dec 2022
Net transactions value
+$24,998
Form type
4
Filing time
19 Dec 2022, 07:01:33 UTC
Previous filing
14 Nov 2022
Next filing
22 May 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCDA Common Stock Award $24,998 +14,880 +4.5% $1.68 347,827 16 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased from the Issuer in a private placement that closed on December 16, 2022.